Last Updated: June 26, 2026

SELENIOUS Drug Patent Profile

Name: SELENIOUS Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Selenious patents expire, and when can generic versions of Selenious launch?

Selenious is a drug marketed by Am Regent, Aspiro, Cipla, Fresenius Kabi Usa, Gland, Kindos, Stira, and Sun Pharm. and is included in eight NDAs. There are two patents protecting this drug.

The generic ingredient in SELENIOUS is selenious acid. Two suppliers are listed for this compound. Additional details are available on the selenious acid profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Selenious

A generic version of SELENIOUS was approved as selenious acid by AM REGENT on April 30^th, 2019.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SELENIOUS?
What are the global sales for SELENIOUS?
What is Average Wholesale Price for SELENIOUS?

Summary for SELENIOUS

US Patents:	0
Applicants:	8
NDAs:	8
DailyMed Link:	SELENIOUS at DailyMed

Drug patent expirations by year for SELENIOUS

US Patents and Regulatory Information for SELENIOUS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Am Regent	SELENIOUS ACID	selenious acid	SOLUTION;INTRAVENOUS	209379-003	Aug 30, 2021	AP	RX	Yes	Yes	12,150,957	⤷ Start Trial				⤷ Start Trial
Aspiro	SELENIOUS ACID	selenious acid	SOLUTION;INTRAVENOUS	219633-001	Jun 11, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Am Regent	SELENIOUS ACID	selenious acid	SOLUTION;INTRAVENOUS	209379-002	Jan 25, 2021	AP	RX	Yes	Yes	11,998,565	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.